CICC Initiates Coverage on Merck with Outperform Rating
On June 24, CICC initiated coverage of Merck & Co., Inc. (NYSE:MRK) with an 'Outperform' rating and a $138 price target. During its Q1 earnings call, Merck updated its full-year guidance for revenue and EPS while excluding the impact of its proposed acquisition of Terns.
Topics: CICC Earnings Guidance Update Merck Outperform Rating